Literature DB >> 7824063

Lack of effect of bilateral locus coeruleus lesion and antidepressant treatment on gamma-aminobutyric acidB receptors in the rat frontal cortex.

A H Engelbrecht1, V A Russell, J J Taljaard.   

Abstract

The aim of the present study was to investigate whether a disturbance of the central noradrenergic (NA) system could cause changes in gamma-aminobutyric acidB (GABAB) receptors in the rat frontal cortex. Manipulation of the NA projection to the frontal cortex was achieved by bilateral lesion of the locus coeruleus with 6-hydroxydopamine (6-OHDA) or chronic treatment with the NA reuptake blocker and antidepressant drug, desipramine. Precautions were taken to ensure that the GABAB receptor assay was performed optimally and was not confounded by the presence of endogenously generated GABA. The results show conclusively that manipulation of the NA projection did not result in any significant change in the number (Bmax) or affinity (Kd) of GABAB receptors in the frontal cortex. These results do not support the hypothesis that hypoactivity of the central NA system can lead to changes in cortical GABAB receptors and that antidepressant drugs act by increasing GABAB receptor binding in the frontal cortex.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824063     DOI: 10.1007/bf00965144

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

Review 1.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

2.  Biochemical identification of multiple GABAB binding sites: association with noradrenergic terminals in rat forebrain.

Authors:  E W Karbon; R Duman; S J Enna
Journal:  Brain Res       Date:  1983-09-12       Impact factor: 3.252

3.  Dysregulation of the noradrenergic system in depression.

Authors:  L J Siever; K L Davis
Journal:  Psychopharmacol Bull       Date:  1984

4.  Effect of chronic imipramine or baclofen on GABA-B binding and cyclic AMP production in cerebral cortex.

Authors:  P D Suzdak; G Gianutsos
Journal:  Eur J Pharmacol       Date:  1986-11-12       Impact factor: 4.432

5.  Antikindling effects of locus coeruleus stimulation: mediation by ascending noradrenergic projections.

Authors:  G K Weiss; J Lewis; C Jimenez-Rivera; A Vigil; M E Corcoran
Journal:  Exp Neurol       Date:  1990-05       Impact factor: 5.330

6.  Evidence that noradrenergic neurons in the A1 and A2 nuclei are lesioned by low doses of 6-OHDA injected into the locus coeruleus.

Authors:  A H Engelbrecht; V Russell; M E Carstens; A S De Villiers; A Searson; A Jaffer; J J Taljaard
Journal:  J Neurosci Methods       Date:  1994-04       Impact factor: 2.390

7.  Functional evidence for altered activity of GABAergic receptors following chronic desipramine treatment in rats.

Authors:  F Borsini; S Giuliani; A Meli
Journal:  J Pharm Pharmacol       Date:  1986-12       Impact factor: 3.765

8.  Biological markers in juvenile depression.

Authors:  M E Carstens; A H Engelbrecht; V A Russell; A M van Zyl; J J Taljaard
Journal:  Psychiatry Res       Date:  1988-01       Impact factor: 3.222

9.  Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock.

Authors:  K G Lloyd; F Thuret; A Pilc
Journal:  J Pharmacol Exp Ther       Date:  1985-10       Impact factor: 4.030

10.  Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder.

Authors:  A S de Villiers; V A Russell; M E Carstens; C Aalbers; C A Gagiano; D O Chalton; J J Taljaard
Journal:  Psychiatry Res       Date:  1987-10       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.